Buying into tomorrow’s drug platforms

3:00 PM - 4:00 PM (PDT), Tuesday, June 14, 2022 ・ Upper Level, Session Room 6F

Partnerships between pharma and biotech hit record levels in 2021 both in terms of deals volume and values. Many of the largest deals saw big pharma secure access to drug discovery platforms – such as gene and cell therapies, RNA technologies, gene editing, and Artificial Intelligence and Machine learning approaches -- that are expected to deliver the next generation of transformative medicines. This panel will explore which technology platforms are potentially most attractive to big pharma and explain what validation needs to be in place for them to start discussions

Sponsored By
Moderator
photo
Partner
Clarivate
Speakers
photo
SVP
Recursion
photo
Executive Chairman
Poseida Therapeutics
photo
CBO
BigHat Biosciences